In view of the sharp increase in the demand for virus detection in this round of epidemic prevention and control, the relevant expenses are paid according to the relevant regulations of novel coronavirus Province on nucleic acid and antibody detection projects; At the same time, it is clear that the expenses for the insured to buy testing reagents at the designated retail pharmacies in our city can be paid by using the personal account of medical insurance. COVID-19 nucleic acid testing costs adjusted in time. The Municipal Medical Insurance Bureau, in coordination with the Municipal Health and Health Commission and public medical institutions, lowered the government-guided price for single-person and single-person inspection of new crown nucleic acid detection to no higher than that of 28 yuan, and lowered the government-guided price for multi-person mixed inspection to no higher than that of 8 yuan, further reducing the burden of nucleic acid detection costs, especially for service industries, small and micro enterprises and employees with high detection frequency.
Two, the medical insurance department continues to retain prepaid working capital.
Actively strengthen contact and communication with the Municipal Health and Health Commission and designated medical institutions, timely understand and master the actual situation and difficulties faced by the hospital, extend the time limit for submitting the monthly medical drug expense report of designated medical institutions on the basis of adopting relevant policy support measures in the early stage, and settle and distribute according to the system data first, so as to reduce the pressure on medical institutions to advance funds and staff to run errands.
Third, during the epidemic prevention and control period, in order to facilitate patients with chronic diseases, the "long prescription" reimbursement policy was implemented for patients with chronic diseases.
In order to do a good job in outpatient medical services for chronic diseases during the period of epidemic normalization prevention and control, according to the requirements of the Prescription Management Measures and the needs of disease treatment, it is stipulated that the attending physician can prescribe a dose of three months at a time, and the maximum monthly payment limit of medical insurance can be calculated every three months.
In order to reduce the risk of epidemic prevention and control caused by large-scale crowd gathering, the medical insurance agency in our city timely adjusted the declaration and review methods of chronic diseases in medical insurance clinics, and tried to take the form of "no meeting" or "less meeting". Patients with chronic diseases do not need to go to the site for centralized review and confirmation after submitting materials to the designated medical institutions, and the medical insurance agency organizes medical experts to conduct centralized review and confirmation on the medical records transferred from the designated medical institutions. If there are doubts about the relevant inspection materials provided in the review materials submitted by patients, or if there is a lack of necessary inspection, patients should be organized to go to the hospital for review in time according to the development of the epidemic situation.